Treatment of Glaucoma Using Laquinimod

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15875833

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The subject invention provides a method of treating a subject afflicted with glaucoma, suffering from retinal ganglion cell (RGC) loss or damage, or elevated intraocular pressure (IOP), or of reducing RGC loss or damage, or reducing IOP in a subject, comprising administering to the subject an amount of laquinimod effective to treat the subject, to reduce RGC loss or damage, or to reduce IOP in the subject. Provide also is a pharmaceutical composition, a package and a therapeutic package for treating a subject afflicted with glaucoma.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA PHARMACEUTICAL INDUSTRIES LTD49131 PETAH TIQVA

International Classification(s)

loading....
  • 2018 Application Filing Year
  • A61J Class
  • 927 Applications Filed
  • 585 Patents Issued To-Date
  • 63.11 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Etzyoni, Revital Kfar-Saba, IL 6 0
Neumann, Ron Ramat Hasharon, IL 7 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • A61J Class
  • 0 % this patent is cited more than
  • 7 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges32542101 - 1011 - 2031 - 4002.557.51012.51517.52022.52527.53032.53537.54042.54547.55052.55557.5

Forward Cite Landscape

Load Citation